Gensight Biologics trades -4.5 percent lower on Monday 26th of OctoberExplore Gensight Biologics’ recent dip—down 4.5%—and its €0.07 share price, market cap, 52‑week highs/lows, and comparison with peers for investors.GENSIGHT BIOLOGICS SAFrance Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Samantha Roth 26/10/2026, 16:13 2 minutes to read
